All 11 RBPs (BRIX1, DYNC1H1, GTPBP4, PRKDC, RAN, RBM19, SF3B4, SMG5, SPATS2, TAF9, and THOC5) were expressed at significantly higher levels in patients with advanced tumor grade. The gene discussed is PRKDC; the disease is neoplasm.